Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Maruishi licenses rights to Chirocaine in Japan

Sep. 7, 1998

Potent mixed delta/mu-opioid agonist identified by Glaxo Wellcome/Delta team

Sep. 4, 1998

Taisho discovers potent and selective CRF1 receptor antagonists with anxiolytic effects

Sep. 4, 1998

P&U, U of Maryland describe inhibitors of kynurenine aminotransferase

Sep. 4, 1998

Neuroprotective and antioxidant phenazines designed at Nippon Chemiphar

Sep. 4, 1998

Regeneron receives milestone payment from Sumitomo related to BDNF development

Sep. 4, 1998

Pfizer/Neurogen anxiolytic advances in clinical trials

Sep. 3, 1998

Pharmacological profile of new acetylcholinesterase inhibitor: T-82

Sep. 3, 1998

Therapeutics for cerebrovascular disorders in development at Nippon Chemiphar

Sep. 3, 1998

Compounds interacting with nicotinic receptors for cognitive and memory deficits

Sep. 2, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 16, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...